• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALERE SAN DIEGO, INC. INRATIO PT/INR TEST STRIPS; PROTHROMBIN TIME TEST

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALERE SAN DIEGO, INC. INRATIO PT/INR TEST STRIPS; PROTHROMBIN TIME TEST Back to Search Results
Model Number 100071
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problems Hematuria (2558); Test Result (2695)
Event Date 01/02/2016
Event Type  Injury  
Manufacturer Narrative
Investigation is pending.
 
Event Description
The caller (end user) alleged a variance between the inratio inr result and an alternate point of care (poc) inr result.The following information was provided.The end user explained that she normally alternates coumadin 7.5mg and 10mg daily and takes the dose at 9:00pm and her therapeutic range is 2.0 - 3.0.Additionally when she tests on the inratio device, she stated that she ties a rubber band around her finger prior to performing all her inratio tests.On (b)(6) 2016, she took coumadin 7.5 mg which was her normal dose for that day.On (b)(6) 2016, the inratio inr was 1.2.She took coumadin 10mg, per physician order.On (b)(6) 2016, the caller took coumadin 10mg, per physician order.On (b)(6) 2016, the caller had a doctor's appointment and an alternate poc inr was 8.0.There was no inratio test performed on that day.Due to blood in her urine and an elevated inr, she was sent to the emergency room.The laboratory inr was 8.0 and she was administered oral vitamin k.On (b)(6) 2016, at the caller's doctor's appointment the alternate poc inr was 5.1 and the inratio inr was 4.6.The time between the two tests was 10 minutes.Coumadin was held for the day.On (b)(6) 2016, at the caller's doctor's appointment the alternate poc inr was 2.9 and she took coumadin 5mg, per physician order.There was no additional information provided.
 
Manufacturer Narrative
Investigation/conclusion: as of 02/25/2016, the product was not returned for evaluation.Therefore, a review of the in-house testing history of the lot was performed.In-house testing on the reported strip lot met release criteria and the product performed as expected.The manufacturing records for the lot were reviewed and the lot met release specifications.The patient's normal coumadin dose was alternating 7.5mg and 10mg.On (b)(6) 2016, the patient took the normal 7.5mg dose and on (b)(6) 2016 after the inratio inr result of 1.2 the normal 10mg dose was taken.On (b)(6) 2016, a 10mg dose of coumadin was taken instead of the normal 7.5mg.Starting, stopping, or changing the dose can affect the inr value.This may have contributed to the difference between the results obtained on (b)(6) 2016.An improper technique was identified in the complaint.This cannot be ruled out as a root cause to customer's unexpected results.A root cause could not be determined from the information provided by the customer.Further investigation under (b)(4) which was initiated to investigate highly discrepant results.
 
Event Description
On (b)(6) 2016, the laboratory inr result was 8.0.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INRATIO PT/INR TEST STRIPS
Type of Device
PROTHROMBIN TIME TEST
Manufacturer (Section D)
ALERE SAN DIEGO, INC.
9975 summers ridge road
san diego CA 92121
Manufacturer (Section G)
ALERE SAN DIEGO, INC.
9975 summers ridge road
san diego CA 92121
Manufacturer Contact
ya-ling king
9975 summers ridge road
san diego, CA 92121
8588052084
MDR Report Key5394811
MDR Text Key36954837
Report Number2027969-2016-00051
Device Sequence Number1
Product Code GJS
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K092987
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,distributor
Reporter Occupation Patient
Remedial Action Recall
Type of Report Initial,Followup
Report Date 01/05/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/27/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Model Number100071
Device Lot Number367839A
Is the Reporter a Health Professional? No
Date Manufacturer Received02/25/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Removal/Correction NumberZ-0880, 0881, 0882-2015
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-